Virtus ETF Advisers LLC Edwards Lifesciences Corp Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $803,884 - $899,340	9,536 New	9,536 $880,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $46,044 - $59,975	559 Added 9.33%	6,548 $541,000
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $518,048 - $768,209	5,989 New	5,989 $569,000
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $8,317 - $9,522	-116 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $7,139 - $8,749	116 New	116 $26,000

1,354

469M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.